0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV82.94%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma10.85Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Keros Therapeutics Stock Discussion
Keros Eyes Potential Sale: Board Weighs Strategic Options Amid Investor Interest
Clinical Trial Success: KER-065 Hits All Safety Targets, Shows Promise for DMD Treatment
No comment yet